Explore

Trendline Trendline
Corbus Pharmaceuticals Appoints Nishant Saxena as Chief Business Officer and Plans ASCO Conference Call

Corbus Pharmaceuticals Appoints Nishant Saxena as Chief Business Officer and Plans ASCO Conference Call

Corbus Pharmaceuticals Appoints Nishant Saxena as Chief Business Officer and Plans ASCO Conference Call
Trendline Trendline
Longeveron Outlines Strategic Repositioning and Key Milestones for 2026

Longeveron Outlines Strategic Repositioning and Key Milestones for 2026

Longeveron Outlines Strategic Repositioning and Key Milestones for 2026
Trendline Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
Trendline Trendline
Eisai Presents New Clinical Evidence for Lenvatinib at ASCO 2026

Eisai Presents New Clinical Evidence for Lenvatinib at ASCO 2026

Eisai Presents New Clinical Evidence for Lenvatinib at ASCO 2026
Trendline Trendline
Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status

Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status

Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status
Trendline Trendline
Innate Pharma to Engage with Investors at Jefferies Global Healthcare Conference in New York

Innate Pharma to Engage with Investors at Jefferies Global Healthcare Conference in New York

Innate Pharma to Engage with Investors at Jefferies Global Healthcare Conference in New York
Trendline Trendline
Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts

Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts

Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts
Trendline Trendline
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Trendline Trendline
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board

TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board

TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
Trendline Trendline
Novastra Therapeutics Appoints New CFO to Propel Global Clinical Development

Novastra Therapeutics Appoints New CFO to Propel Global Clinical Development

Novastra Therapeutics Appoints New CFO to Propel Global Clinical Development
Trendline Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Trendline Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase